Health Sciences Trust is a registered fund series of John Hancock Variable Insurance Trust (series S000008239). Net assets $227.2M as of 2026-03-31.
Showing 15 of 175 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly and Company | — | $23.2M | 1020.38% |
| Thermo Fisher Scientific Inc. | — | $9.4M | 412.13% |
| Intuitive Surgical Inc. | — | $8.4M | 370.76% |
| Stryker Corporation | — | $8.0M | 352.05% |
| Merck and Co. Inc. | — | $7.9M | 347.74% |
| AstraZeneca PLC | — | $7.3M | 322.26% |
| UnitedHealth Group Incorporated | — | $7.1M | 313.30% |
| argenx SE | — | $6.8M | 299.33% |
| AbbVie Inc. | — | $6.6M | 288.34% |
| Regeneron Pharmaceuticals Inc. | — | $6.1M | 268.80% |
| Gilead Sciences Inc. | — | $6.0M | 264.36% |
| Johnson and Johnson | — | $5.6M | 247.12% |
| Vertex Pharmaceuticals Incorporated | — | $5.6M | 246.20% |
| Danaher Corporation | — | $4.7M | 208.30% |
| Alnylam Pharmaceuticals Inc. | — | $3.8M | 168.05% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $227.2M |
| 2025-12-31 | $246.2M |
| 2025-09-30 | $216.9M |
| 2025-06-30 | $212.7M |
| 2025-03-31 | $228.3M |
| 2024-12-31 | $235.8M |
| 2024-09-30 | $268.9M |
| 2024-06-30 | $261.7M |